Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer
- 1 August 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (8) , 803-807
- https://doi.org/10.1053/hupa.2001.26455
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The control of T cell responses by dendritic cell subsetsCurrent Opinion in Immunology, 2000
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapyPathology, 1999
- The Effect of Interferon-γ and Tumor Necrosis Factor-α on the Expression of ICAM-1 and HLA-DR Molecules on Cells of a Human Germ Cell Neoplasm and Their Susceptibility to Lysis by Lymphokine-Activated Killer CellsPathobiology, 1998
- Expression of Maturation-/Migration-Related Molecules on Human Dendritic Cells from Blood and SkinImmunobiology, 1998
- Origin, maturation and antigen presenting function of dendritic cellsCurrent Opinion in Immunology, 1997
- Heterogeneity of Pituitary Folliculo‐Stellate Cells: Implications for Interleukin‐6 Production and Accessory Function in vitroJournal of Neuroendocrinology, 1997
- Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic studyPathology, 1996
- A new Histologic Grading Index in Ovarian CarcinomaInternational Journal of Gynecological Pathology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988